Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 37(8): 848-858, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29069929

RESUMO

Etoposide (ETO) and methotrexate (MTX) are two effective chemotherapeutic drugs. However, the clinical use of these drugs is limited by its toxicity in normal tissues, especially in kidney and in liver tissues. Recombinant human erythropoietin (rhEPO), erythropoietin hormone, has also been shown to exert tissue protective effects. The purpose of this study was to explore the protective effect of rhEPO against oxidative stress and genotoxicity induced by ETO and MTX in vivo. Adult male Wistar rats were divided into 10 groups (6 animals each): control group, rhEPO alone group, ETO alone group, MTX alone group and rhEPO + ETO/MTX groups. In rhEPO + ETO/MTX groups, three doses of pretreatment with rhEPO were performed: 1000, 3000 and 6000 IU/kg. Our results showed that rhEPO pretreatment protects liver and kidney tissues against oxidative stress induced by the anticancer drugs. The glycoprotein decreased malondialdehyde (MDA) levels, reduced catalase activity and ameliorated glutathione depletion. Furthermore, we showed that rhEPO administration prevented drug-induced DNA damage accessed by comet test. Altogether, our results suggested a protective role of rhEPO, especially at 3000 IU/kg, against ETO- and MTX-induced oxidative stress and genotoxicity in vivo.


Assuntos
Antimetabólitos Antineoplásicos/toxicidade , Antineoplásicos Fitogênicos/toxicidade , Eritropoetina/uso terapêutico , Etoposídeo/toxicidade , Metotrexato/toxicidade , Substâncias Protetoras/uso terapêutico , Animais , Catalase/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/genética , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Dano ao DNA , Eritropoetina/farmacologia , Glutationa/metabolismo , Rim/efeitos dos fármacos , Rim/metabolismo , Nefropatias/induzido quimicamente , Nefropatias/genética , Nefropatias/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Malondialdeído/metabolismo , Substâncias Protetoras/farmacologia , Ratos Wistar , Proteínas Recombinantes/farmacologia , Proteínas Recombinantes/uso terapêutico
2.
J Med Case Rep ; 11(1): 7, 2017 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-28049508

RESUMO

BACKGROUND: Hepatocellular carcinoma has a poor prognosis; few patients can undergo surgical curative treatment according to Barcelona Clinic Liver Cancer guidelines. Progress in surgical techniques has led to operations for more patients outside these guidelines. Our case shows a patient with intermediate stage hepatocellular carcinoma presenting a good outcome after curative treatment. CASE PRESENTATION: We report the case of an 80-year-old Moroccan man, who was positive for hepatitis c virus, presenting an intermediate stage hepatocellular carcinoma (three lesions between 20 and 60 mm). He presented a complete tumor necrosis after portal vein embolization and achieved 24-month disease-free survival after surgery. CONCLUSIONS: Perioperative care in liver surgery and multidisciplinary discussion can help to extend indications for liver resection for hepatocellular carcinoma outside European Association for the Study of the Liver/American Association for the Study of Liver Diseases recommendations and offer a curative approach to selected patients with intermediate and advanced stage hepatocellular carcinoma.


Assuntos
Dor Abdominal/diagnóstico por imagem , Carcinoma Hepatocelular/patologia , Embolização Terapêutica , Neoplasias Hepáticas/patologia , Veia Porta/patologia , Tomografia Computadorizada por Raios X , Idoso de 80 Anos ou mais , Carcinoma Hepatocelular/diagnóstico por imagem , Carcinoma Hepatocelular/terapia , Intervalo Livre de Doença , Humanos , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/terapia , Masculino , Cuidados Pré-Operatórios , Resultado do Tratamento
3.
Toxicon ; 48(3): 343-52, 2006 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-16884754

RESUMO

T-2 toxin belongs to a group of mycotoxins synthesized by Fusarium fungi that are widely encountered as natural contaminants of certain important agricultural commodities particularly, cereals. Upon exposure, T-2 toxin causes severe human and animal diseases. It is considered to be a major causative agent in fatal alimentary toxic aleukia (ATA) in humans. In this study, cytotoxicity and apotosis induction by T-2 toxin was investigated in vitro on Vero cell line using the MTT and the neutral red viability assays, the induction of lipid peroxidation, the decrease of macromolecule levels (protein, DNA and RNA), DNA fragmentation and caspase-3-dependent apoptosis induction. Our results showed that T-2 toxin reduced cell viability correlated to an impairment of macromolecule levels. It also increased MDA formation, induced DNA fragmentation showed by DNA laddering patterns on agarose gel electrophoresis. This fragmentation is in relation with apoptosis induction which was confirmed by activation of caspase-3, and depletion of the mitochondrial membrane potential reflecting a mitochondrial dysfunction.


Assuntos
Sobrevivência Celular/efeitos dos fármacos , Toxina T-2/toxicidade , Animais , Apoptose/efeitos dos fármacos , Caspase 3 , Caspases/metabolismo , Chlorocebus aethiops , DNA/efeitos dos fármacos , Eletroforese em Gel de Ágar , Ativação Enzimática , Peroxidação de Lipídeos/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , RNA/efeitos dos fármacos , Células Vero
4.
Hum Exp Toxicol ; 35(1): 53-62, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25733728

RESUMO

Mitomycin C (MMC) is an antineoplastic agent used for the treatment of several human malignancies. Nevertheless, the prolonged use of the drug may result in a serious heart and kidney injuries. Recombinant human erythropoietin (rhEPO) has recently been shown to exert an important cytoprotective effect in experimental brain injury and ischemic acute renal failure. The aim of the present work is to investigate the cardioprotective and renoprotective effects of rhEPO against MMC-induced oxidative damage and genotoxicity. Our results showed that MMC induced oxidative stress and DNA damage. rhEPO administration in any treatment conditions decreased oxidative damage induced by MMC. It reduced malondialdehyde and protein carbonyl levels. rhEPO ameliorated reduced glutathione plus oxidized glutathione modulation and the increased catalase activity after MMC treatment. Furthermore, rhEPO restored DNA damage caused by MMC. We concluded that rhEPO administration especially in pretreatment condition protected rats against MMC-induced heart and renal oxidative stress and genotoxicity.


Assuntos
Eritropoetina/farmacologia , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Mitomicina/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Alquilantes/efeitos adversos , Animais , Catalase/metabolismo , Ensaio Cometa , Dano ao DNA , Esquema de Medicação , Glutationa , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Testes de Mutagenicidade , Miocárdio , Carbonilação Proteica , Ratos
5.
Hum Exp Toxicol ; 35(6): 623-34, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26231423

RESUMO

Zearalenone (ZEN) is a mycotoxin from Fusarium species commonly found in food commodities and is known to cause reproductive disorders. Several in vivo studies have shown that ZEN is haematotoxic and hepatotoxic and causes several alterations of immunological parameters. Meantime, the available information on the cardiotoxic effects of ZEN is very much limited. In the present study, we investigated the toxic effects of ZEN in heart tissues of Balb/c mice. We demonstrated that ZEN (40 mg kg(-1) body weight (b.w.)) increased creatine phosphokinase, lactate dehydrogenase, aspartate transaminase, alanine transaminase, total cholesterol and triglyceride levels and induced oxidative stress as monitored by measuring the malondialdehyde level, the generation of protein carbonyls, the catalase and superoxide dismutase activity and the expression of the heat shock proteins (Hsp 70). We also demonstrated that acute administration of ZEN triggers apoptosis in cardiac tissue. Furthermore, we aimed to evaluate the safety and efficacy of crocin (CRO), a natural carotenoid, to prevent ZEN-induced cardiotoxicity in mice. In fact, combined treatment of ZEN with different doses of CRO (50, 100, and 250 mg kg(-1) b.w.) showed a significant reduction of ZEN-induced toxicity for all tested markers in a dose-dependent manner. It could be concluded that CRO was effective in the protection against ZEN-induced toxicity in cardiac tissue.


Assuntos
Antioxidantes/farmacologia , Apoptose/efeitos dos fármacos , Carotenoides/farmacologia , Coração/efeitos dos fármacos , Miocárdio , Estresse Oxidativo/efeitos dos fármacos , Zearalenona/toxicidade , Animais , Antioxidantes/metabolismo , Antioxidantes/uso terapêutico , Western Blotting , Cardiotoxicidade/prevenção & controle , Carotenoides/uso terapêutico , Relação Dose-Resposta a Droga , Contaminação de Alimentos , Peroxidação de Lipídeos/efeitos dos fármacos , Camundongos Endogâmicos BALB C , Miocárdio/metabolismo , Miocárdio/patologia
6.
Biochim Biophys Acta ; 653(2): 145-59, 1981 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-7013810

RESUMO

The interactions between yeast tRNAphe and phenylalanyl-tRNA synthetase were studied by analysis of the covalent adducts obtained upon monochromatic ultraviolet irradiation at different wavelengths (248, 282, 292, 302 and 313 nm). The high extent of inactivation of phenylalanyl-tRNA synthetase, together with the partial modification of tRNA, as well as the peculiar instability of most of the covalent bonds formed upon irradiation constitute severe limitations to the use of the technique and to the interpretation of the results. These disadvantages led us to select an irradiation wavelength of 248 nm and to use only mild isolation procedures allowing a good recovery of the covalent adducts formed. Seven major tryptic peptides of the enzyme were found to be cross-linked to tRNAPhe whereas six major T1-oligonucleotides were covalently linked to the protein, among these, the three cross-linked oligonucleotides previously described by Shoemaker and Schimmel (J. Biol. Chem. 250 (1975) 4440-4444) in the same system. The difference in the number of covalently linked oligonucleotides is discussed in the light of the instability of the covalent linkages. The localization of the six oligonucleotides at the inside of the two branches forming the L-shaped tRNA molecule is similar to that observed in the yeast valine system (Renaud et al., Eur. J. Biochem. 101 (1979) 475-483) and is consistent with the interaction model previously described (Rich and Schimmel, Nucl. Acids Res. 4 (1977) 1649-1665 and Ebel et al. in Transfer RNA: structure, properties and recognition, (1979) pp. 325-343 Cold Spring Harbor Laboratory, NY). The occurrence of covalent cross-linking upon irradiation in the tryptophan absorption band (302 nm) strongly suggests the participation of this residue in the stabilization of the tRNA enzyme complex.


Assuntos
Aminoacil-tRNA Sintetases/metabolismo , Fenilalanina-tRNA Ligase/metabolismo , RNA de Transferência/metabolismo , Saccharomyces cerevisiae/metabolismo , Raios Ultravioleta , Cinética , Oligopeptídeos/efeitos da radiação , Oligorribonucleotídeos/efeitos da radiação , Oxirredução , Ligação Proteica , RNA de Transferência/efeitos da radiação
7.
Mutat Res ; 565(2): 139-49, 2005 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-15661612

RESUMO

The cytogenetic effect of zearalenone (ZEN), a non-steroidal estrogenic mycotoxin, was evaluated in vivo, in mouse bone marrow cells, by assessing the percentage of cells bearing different chromosome aberrations. The studies included different conditions for animal treatment, as follows: (1) single intraperitoneal (ip) injection, (2) repeated ip injections, (3) pre-treatment for 24h with Vitamin E (Vit E), and (4) pre-treatment for 4h with 17beta-estradiol (17beta-Est) or progesterone (Prog). ZEN induced different types of chromosome aberrations, which was concentration-dependent (2-20 mg/kg bw). These doses corresponded to 0.4-4% of the LD50 in the mouse. Interestingly, when the dose of ZEN (40 mg/kg) was fractionated into four equivalent doses (4 x 10 mg/kg bw), into three doses (15 + 10 + 15 mg/kg bw), or into two equivalent doses (2 x 20 mg/kg bw), given every 24 h, the percentage of chromosome aberrations increased significantly. This finding suggests that ZEN proceeds by reversible binding on receptors that could become saturated, and that it damages the chromosomes in a 'hit and go' manner. Furthermore, pre-treatment of animals with 17beta-estradiol or progesterone significantly decreased the percentage of chromosome aberrations, suggesting that (i) these hormones bind to the same cytoplasmic receptors transported into the nucleus to elicit DNA damage, (ii) they may play a role in preventing chromosome aberrations induced by ZEN. Similarly, Vit E prevented these chromosome aberrations indicating that Vit E, previously reported to prevent most of the toxic effects induced by ZEN, may also bind to the same receptors.


Assuntos
Células da Medula Óssea/efeitos dos fármacos , Cromossomos/efeitos dos fármacos , Estradiol/farmacologia , Estrogênios não Esteroides/farmacologia , Progesterona/farmacologia , Vitamina E/farmacologia , Zearalenona/farmacologia , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Células da Medula Óssea/citologia , Células da Medula Óssea/metabolismo , Aberrações Cromossômicas , Estradiol/metabolismo , Estrogênios não Esteroides/química , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Progesterona/metabolismo , Distribuição Aleatória , Vitamina E/metabolismo , Zearalenona/química
8.
Hum Exp Toxicol ; 34(11): 1119-32, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25645822

RESUMO

Gastrointestinal risk factors after organ transplantation are prevalent, due to the chronic use of immunosuppressant. The immunosuppressive drugs such as tacrolimus/mycophenolate mofetil (TAC/MMF) association are the most commonly used therapy. TAC and MMF have been implicated in gastrotoxicity, but their direct effects, alone and combined, on intestinal cells are not completely elucidated. This study investigated the effect of TAC and MMF alone and combined on human colon carcinoma cells. Our results demonstrated that TAC and MMF individually inhibit clearly cells proliferation, enhanced free radicals, lipid peroxidation production, induced DNA lesions and reduced mitochondrial membrane potential. In this study, we also showed that the two molecules TAC and MMF combined at high concentrations amplified the cell damage. Furthermore, the TAC (5 µM) prevented cell death induced by MMF (half maximal inhibitory concentration (IC(50))). Also, MMF (50 µM) induced cytoprotection in HCT116 cells against TAC (IC(50)) toxicity. Our findings provide additional evidence that oxidative damage is the major contribution of TAC and MMF combined toxicities. In fact, MMF and TAC exert a gastroprotective effect by modulating reactive oxygen species production. These data underscore the pleiotropic effect of TAC and MMF on HCT116 cells that play a preventive and critical role on intestinal function.


Assuntos
Antioxidantes/farmacologia , Imunossupressores/farmacologia , Ácido Micofenólico/análogos & derivados , Estresse Oxidativo/efeitos dos fármacos , Tacrolimo/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Ensaio Cometa , Dano ao DNA , Interações Medicamentosas , Células HCT116 , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Ácido Micofenólico/farmacologia , Espécies Reativas de Oxigênio/metabolismo
9.
Hum Exp Toxicol ; 34(5): 468-78, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25304971

RESUMO

Mitomycin C (MMC) is one of the most effective chemotherapeutic drugs. However, the dose of MMC is greatly limited by its toxicity in normal tissues. Recombinant human erythropoietin (rhEPO), an erythropoietic hormone, has also been shown to exert tissue protective effects. The purpose of this study was to explore the protective effect of rhEPO against MMC-induced heart, liver, and renal dysfunction. Adult male Wistar rats were divided into six groups (with six animals each), namely control, rhEPO alone group, MMC alone group, and rhEPO + MMC group (pre-, co-, and posttreatment conditions). The results showed that MMC induced a marked cardiac, renal, and liver failure characterized by a significant decrease in body weight, organs weight, and organs ratio and a significant increase in creatinine, blood urea nitrogen, alanine aminotransferase, aspartate aminotransferase, γ-glutamyl transferase, and conjugated and total bilirubin levels in serum. Histological examination showed that MMC caused liver alterations. rhEPO treatment restored body weight, organs weight, and organs ratio as well as serum biochemical parameters and histological damage caused by MMC exposure.


Assuntos
Antibióticos Antineoplásicos/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Eritropoetina/uso terapêutico , Insuficiência Cardíaca/prevenção & controle , Mitomicina/efeitos adversos , Insuficiência Renal/prevenção & controle , Animais , Cardiotoxicidade , Doença Hepática Induzida por Substâncias e Drogas/sangue , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/patologia , Esquema de Medicação , Eritropoetina/administração & dosagem , Insuficiência Cardíaca/sangue , Insuficiência Cardíaca/induzido quimicamente , Insuficiência Cardíaca/patologia , Testes de Função Renal , Testes de Função Hepática , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ratos Wistar , Proteínas Recombinantes , Insuficiência Renal/sangue , Insuficiência Renal/induzido quimicamente , Insuficiência Renal/patologia
10.
Cancer Lett ; 114(1-2): 225-9, 1997 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-9103298

RESUMO

Ochratoxin A (OTA), and zearalenone (ZEN), two mycotoxins, have been implicated in numerous mycotoxicoses in farm animals and are genotoxic. Several adducts were detected in mouse and rat kidney after a single administration of OTA and in mice organs after zearalenone treatment which induces hepatocellular adenomas. The effects of some vitamins such as retinol (A), ascorbic acid (C) and alpha-tocopherol (E), which are known to act as superoxide anion scavengers, were tested on OTA genotoxicity. Pretreatment of mice by vitamin E decreased DNA adducts by 80% in kidney. Vitamin A decreased DNA adduct levels by 70% and Vitamin C by 90% in kidney. In the same way, pretreatment of female mice with alpha-tocopherol before administration of zearalenone inhibited significantly DNA adduct formation in liver and in kidney. The total DNA adduct level after E treatment was decreased by 45% and 58% in liver and kidney respectively.


Assuntos
Ácido Ascórbico/farmacologia , Adutos de DNA/efeitos dos fármacos , Ocratoxinas/farmacologia , Vitamina A/farmacologia , Vitamina E/farmacologia , Zearalenona/farmacologia , Animais , Feminino , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Micotoxinas/farmacologia
11.
Toxicon ; 34(5): 535-40, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8783448

RESUMO

Zearalenone produced by the fungus Fusarium roseum causes important perturbations in the gestation cycle of the rat with hormonal disorders and infertility. In order to find out other eventual toxic effects, female rats were given intraperitoneally (i.p.) (1.5, 3 and 5 mg/kg) zearalenone in sterile olive oil. Forty-eight hours later, some blood parameters changed (hematocrit, MCV, the number of platelets and WBC) as well as some biochemical markers such as aminotransferases (ALT, AST), alkaline phosphatase (ALP), serum creatinine, bilirubin, indicating liver toxicity, and likely impairment of blood coagulation process.


Assuntos
Biomarcadores/sangue , Estrogênios não Esteroides/toxicidade , Zearalenona/toxicidade , Fosfatase Alcalina/sangue , Animais , Bilirrubina/sangue , Coagulação Sanguínea/efeitos dos fármacos , Plaquetas/efeitos dos fármacos , Coleta de Amostras Sanguíneas , Contagem de Células/efeitos dos fármacos , Tamanho Celular/efeitos dos fármacos , Creatinina/sangue , Estrogênios não Esteroides/administração & dosagem , Feminino , Hematócrito , Hemoglobinas/metabolismo , Injeções Intraperitoneais , Leucócitos/efeitos dos fármacos , Azeite de Oliva , Óleos de Plantas/administração & dosagem , Ratos , Ratos Wistar , Transaminases/sangue , Zearalenona/administração & dosagem
12.
Toxicology ; 76(3): 233-43, 1992 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-1471160

RESUMO

Three new natural mycotoxins, analogues of ochratoxin A, in which the phenylalanine moiety is replaced by serine, hydroxyproline or lysine, were isolated from cultures of Aspergillus ochraceus by TLC followed by HPLC column chromatography. Their structures were determined after acidic hydrolysis by the characterisation of both their amino acid moieties and of ochratoxin alpha, the chlorinated dihydroisocoumarin moiety of ochratoxin A. These structures were confirmed by mass spectrum analysis.


Assuntos
Aspergillus ochraceus/metabolismo , Ocratoxinas/química , Cromatografia Líquida de Alta Pressão , Cromatografia em Camada Fina , Espectrometria de Massas , Ocratoxinas/isolamento & purificação
13.
Chem Biol Interact ; 113(1): 15-25, 1998 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-9630844

RESUMO

Zearalenone (Zen) is an oestrogenic mycotoxin produced by several Fusarium species in cereals. It induces modifications of haematological parameters in rats with cytotoxicity and inhibition of macromolecular synthesis (nucleic acids and protein). Zen and its metabolites have oestrogenic and anabolic activities and interact with human oestrogen receptors. Zen and its metabolites showed a positive DNA damaging effect in recombination tests with Bacillus subtilis. It induces sister chromatid exchange and chromosomal aberration in CHO cells. Zen was found to be capable of inducing DNA-adduct formation in mouse liver. The genotoxicity of Zen was questionable until the last decade when increasing data tended to show this toxin to be genotoxic in vivo. However the mechanism of its genotoxicity and mutagenicity has not been completely clarified. The present investigations were designed to show whether Zen induces an SOS-DNA repair response in lysogenic bacteria which have an integrated lambda-bacteriophage in their genome. Zen was found to be genotoxic in the bacterial systems from a concentration of 1.50 mM and it was also bactericidal (IC50 = 1.45 mM). In addition vitamin E (6.0-12.0 mM) added 1 h prior to the toxin proved to prevent both the genotoxic and bactericidal effects of Zen. This vitamin could be active both as an antioxidant and as a radical scavenger. The specificity of this prevention is probably due to the similarity of structure between vitamin E and Zen.


Assuntos
Resposta SOS em Genética/efeitos dos fármacos , Vitamina E/farmacologia , Zearalenona/antagonistas & inibidores , Zearalenona/toxicidade , Animais , Antioxidantes/farmacologia , Bacteriófago lambda/efeitos dos fármacos , Bacteriófago lambda/crescimento & desenvolvimento , Reparo do DNA/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Escherichia coli/virologia , Sequestradores de Radicais Livres/farmacologia , Humanos , Lisogenia , Camundongos , Ratos , Ativação Viral/efeitos dos fármacos
14.
Toxicol Lett ; 45(2-3): 307-13, 1989 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2919408

RESUMO

Ochratoxin B (OTB), the dechloro-analogue of ochratoxin A (OTA), was studied separately and in combination with OTA on the aminoacylation of phenylalanine tRNA (tRNAPhe) catalysed by mice liver phenylalanyl-tRNA synthetase. OTB was neither a significant inhibitor of the reaction nor an antagonist of OTA. OTB was also assayed for its possible antagonistic effect on the in vivo protein synthesis inhibition caused by OTA in hepatoma tissue culture cells. No prevention of OTA inhibition could be found for OTB. It rather showed a slight additional inhibitory activity when mixed (100-180 microM) with low concentrations of OTA (40-60 microM). In conclusion, these results are not in favor of an antagonistic effect of OTB with respect to OTA action, at least on the level of cellular protein synthesis.


Assuntos
Neoplasias Hepáticas Experimentais/metabolismo , Ocratoxinas/farmacologia , Biossíntese de Proteínas , RNA de Transferência Aminoácido-Específico/biossíntese , RNA de Transferência de Fenilalanina/biossíntese , Animais , Leucina/metabolismo , Camundongos , Ocratoxinas/antagonistas & inibidores , Ratos , Células Tumorais Cultivadas
15.
Toxicol In Vitro ; 18(4): 467-74, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15130604

RESUMO

Mycotoxins are toxic metabolites of various fungi commonly found in feed and foodstuff and can cause very serious health problems in animals as well as in humans. Zearalenone (ZEN), a mycotoxin produced by various Fusarium species has several adverse effects. Indeed, ZEN has strong estrogenic activity associated with hyperestrogenism and several physiological alterations of the reproductive tract. Moreover, ZEN was shown to be hepatotoxic, haematotoxic, immunotoxic and genotoxic. The exact mechanism of ZEN toxicity is not completely established. The observed strong estrogenic effect of ZEN resulting from its competition with 17beta-estradiol in the binding to estrogen receptors is generally considered to underline most toxic effects of ZEN, but estrogenic activity alone cannot explain the diverse and apparent adverse effects. The objective of the present study was to determine the involvement of other possible mechanisms in ZEN induced toxicity. Cytotoxicity, cell cycle perturbation, inhibition of protein and DNA synthesis as well as the presumed later marker of oxidative stress, malondialdehyde, were monitored in Vero and Caco-2 cells exposed to ZEN. Our results showed that ZEN reduces cell viability correlated to cell cycle perturbation, inhibits protein and DNA syntheses and increases MDA formation in both cell lines in concentration-dependant manner. We assumed that cytotoxicity and oxidative damage are additional mechanisms of ZEN mediated toxicity.


Assuntos
Ciclo Celular/efeitos dos fármacos , DNA/biossíntese , Biossíntese de Proteínas/efeitos dos fármacos , Zeranol/análogos & derivados , Zeranol/toxicidade , Animais , Células CACO-2 , Chlorocebus aethiops , Humanos , Peroxidação de Lipídeos , Malondialdeído/análise , Estresse Oxidativo , Células Vero , Zeranol/farmacologia
16.
Hum Exp Toxicol ; 14(7): 609-14, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7576823

RESUMO

The determination of ochratoxin A (OTA) in human blood in Tunisian populations is underway. The range of contamination is between 0.7 to 7.8 ng ml-1 for the general population and 12 to 55 ng ml-1 for people suffering from chronic renal failure. It appears that 21 to 64% of people suffering from nephropathy are OTA positive with a detection limit of 1ng ml-1. This situation prompted us to search for possible association of OTA contamination and nephropathy resembling Balkan endemic nephropathy. The classification of the ill population into chronic interstitial nephropathy (CIN), chronic glomerular nephropathy (CGN), chronic vascular nephropathy (CVN) and others, indicated that the largest is the CIN group which is significantly different from the other groups, and from the control (P < 0.005). Furthermore, it presented the highest OTA mean values (25 to 59 ng ml-1) compared with the control, CGN, CVN and other groups (6 to 18 ng ml-1) according to the designated region in Tunisia. The rural population seems to be more exposed to ochratoxins in Tunisia, as has been previously reported in the Balkans and Western Europe. Altogether, these results emphasise that in Tunisia an endemic ochratoxin-related nephropathy is probably occurring.


Assuntos
Nefropatias/induzido quimicamente , Ocratoxinas/sangue , Adulto , Idoso , Feminino , Contaminação de Alimentos , Humanos , Nefropatias/sangue , Nefropatias/epidemiologia , Masculino , Pessoa de Meia-Idade , Micotoxinas/efeitos adversos , Micotoxinas/sangue , Ocratoxinas/efeitos adversos , Tunísia/epidemiologia
17.
Hum Exp Toxicol ; 18(6): 410-5, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10413246

RESUMO

Cases of karyomegaly were described by Sclare and by Mihatch in patients affected with tubular-interstitial nephropathy. The Karyomegalic cells showed enlarged nuclei with accumulation of genetic material. No aetiology was suggested. Our study of rats experimentally intoxicated by ochratoxin A, a well-known nephrotoxic compound, indicates the presence of karyomegaly with alteration of the tubular tissue. In control animals no karyomegalic cells were detected. These observations suggest that karyomegaly with megacytosis may be caused by the nephrotoxic ochratoxin A in the kidney. In addition abnormal mitosis together with karyomegalic cells were observed at an earlier stage of the intoxication (30 days) suggesting possible regeneration if the OTA insults are stopped. After 90 days of treatment, the degeneration increased and only karyomegalic and apoptotic-like cells were observed indicating that the regeneration no longer occurs and that the degeneration becomes irreversible.


Assuntos
Núcleo Celular/efeitos dos fármacos , Núcleo Celular/patologia , Nefropatias/induzido quimicamente , Nefropatias/patologia , Túbulos Renais/ultraestrutura , Micotoxinas/toxicidade , Ocratoxinas/toxicidade , Animais , Apoptose/efeitos dos fármacos , Rim/anatomia & histologia , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Nefropatias/genética , Túbulos Renais/efeitos dos fármacos , Túbulos Renais/metabolismo , Túbulos Renais/patologia , Micotoxinas/sangue , Micotoxinas/farmacocinética , Micotoxinas/urina , Ocratoxinas/sangue , Ocratoxinas/farmacocinética , Ocratoxinas/urina , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Wistar
18.
Rev Soc Bras Med Trop ; 32(6): 713-9, 1999.
Artigo em Português | MEDLINE | ID: mdl-10881110

RESUMO

Few cases of concurrent leishmaniasis and HIV infection have been reported in Brazil, despite both infections being in expansion. Two cases of visceral leishmaniasis and two cases of mucocutaneous leishmaniasis are discussed. Disseminated skin and oral lesions were found in the patients with the cutaneous form of the disease. Prolonged fever, hepatosplenomegaly and pancytopenia were the main manifestations of the visceral form. The CD4 T lymphocyte count was low in all cases. Direct examination of bone marrow aspirate for leishmania and biopsy of cutaneous lesions are the techniques of choice to confirm diagnosis. Pentavalent antimonials and amphotericin B are preferred drugs for the treatment of leishmaniasis, including patients with AIDS. The authors recommend the inclusion of this parasitosis in the differential diagnosis of opportunistic diseases in patients with AIDS.


Assuntos
Infecções por HIV/complicações , Leishmaniose/complicações , Adulto , Humanos , Masculino
19.
Arch Inst Pasteur Tunis ; 71(1-2): 21-31, 1994.
Artigo em Francês | MEDLINE | ID: mdl-7661650

RESUMO

Ochratoxin A (OTA) is a mycotoxin which has been implicated in Balkan Endemic Nephropathy (BEN), a disease characterized by tubulonephritis and may be involved in the high incidence of urinary tract tumors associated to BEN. The prevalence of human ochratoxicosis is being determined in Tunisia. 100% of people suffering from chronic interstitial nephropathy of unknown etiology were ochratoxin A positive. These nephropathies are similar to Balkan Endemic Nephropathy. We prove an OTA genotoxic effects in patient suffering from this kind of nephropathy. OTA-DNA adducts formation has been detected in DNA of kidney tissues (biopsy). DNA adducts which are covalent complex between OTA and DNA base (Guanine), constitute first steps of the carcinogenesis process.


Assuntos
Aspergilose/complicações , Aspergillus ochraceus , DNA Fúngico/análise , Nefrite Intersticial/microbiologia , Ocratoxinas/efeitos adversos , Aspergilose/microbiologia , Aspergilose/patologia , Biópsia , Doença Crônica , Adutos de DNA/análise , Humanos , Masculino , Pessoa de Meia-Idade , Nefrite Intersticial/patologia , Ocratoxinas/química , Prevalência , Tunísia
20.
Hum Exp Toxicol ; 32(4): 407-17, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23111886

RESUMO

Cisplatin (Cisp) is one of the most effective chemotherapeutic drugs. However, the dose of Cisp is greatly limited by its toxicity. Recombinant human erythropoietin (rhEPO), a hormone that regulates hematopoiesis, has also been shown to exert tissue-protective effects. The purpose of this study was to explore the protective effect of rhEPO against Cisp-induced renal and liver dysfunctions. Adult male Wistar rats were divided into six groups of six each: control, rhEPO-alone group, Cisp-alone group and rhEPO + Cisp group (pretreatment, cotreatment and posttreatment conditions). Our results showed that Cisp-induced a marked renal and liver failure characterized by a significant decrease in body weight, organ weight and organ ratio and a significant increase in creatinine, blood urea nitrogen, alanine aminotransferase, aspartate aminotransferase, G-glutamyl transferase, alkaline phosphatase, bilirubin conjugated and bilirubin total levels in serum. Histological examination showed that Cisp caused kidney alterations. rhEPO treatments restored body weight, organ weight and organ ratio as well as serum biochemical parameters changed due to Cisp exposure.


Assuntos
Antineoplásicos/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Cisplatino/efeitos adversos , Eritropoetina/administração & dosagem , Nefropatias/tratamento farmacológico , Substâncias Protetoras/administração & dosagem , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Animais , Antineoplásicos/administração & dosagem , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Nitrogênio da Ureia Sanguínea , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/patologia , Cisplatino/administração & dosagem , Creatinina/sangue , Nefropatias/induzido quimicamente , Nefropatias/metabolismo , Nefropatias/patologia , Ratos , Ratos Wistar , Proteínas Recombinantes/administração & dosagem , gama-Glutamiltransferase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA